KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

Mubadala Capital, the investment arm of Abu Dhabi’s sovereign wealth fund, has secured a majority stake in the high-profile baby buggy manufacturer Bugaboo. This strategic acquisition underscores ...

Abu Dhabi Open - Day 2Mubadala Abu Dhabi Open Women Single Abu Dhabi Open - Day 3Mubadala Abu Dhabi Open Women Single Abu Dhabi Open - Day 4Mubadala Abu Dhabi Open ...

A strategic move that further supports Mubadala’s efforts to advance the UAE's life sciences sector Following the acquisition of four GlobalOne Healthcare Holding assets, this transaction represents ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

RIYADH, Jan 19 (Reuters) - Turkish grocery delivery company Getir and its biggest shareholder, Abu Dhabi state investment fund Mubadala, remained at odds on Sunday over a restructuring plan which ...

Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary of Ras Al Khaimah-headquartered ...

Getir founders allege Mubadala breached restructuring agreement Mubadala claims founders failed to complete June agreement Mubadala says it will present new plan to Getir shareholders in coming ...